Core Insights - Cavitation Technologies, Inc. (CTi) has reported significant milestones in 2025, transitioning its Cavitation Non-Thermal Plasma™ (CNTP™) technology from development to pilot installations, supported by key partnerships in industrial and water treatment sectors [1][3] - The company is expanding into the immersion technology market and digital payment infrastructure through its subsidiary, XYRA Corp., which focuses on next-generation applications [1][5] Company Developments - The CNTP™ technology combines hydrodynamic cavitation with non-thermal plasma to effectively break down contaminants in water without chemicals, currently operating at 20 gallons per minute (GPM) and scalable to higher flow rates [3][4][18] - CTi is pursuing applications in various sectors including industrial water remediation, agriculture, pharmaceuticals, and PFAS removal, while also enhancing its focus on produced and frac water applications through Nano-Reactor systems [4][11] XYRA Corp. Initiatives - XYRA Corp. was established to leverage CNTP™ technology for applications in immersion cooling and digital payment infrastructure, targeting advanced fluid applications and fintech solutions [5][15] - The subsidiary aims to modernize crypto-related infrastructure and create an AI-driven, quantum-secure remittance network to facilitate instant, low-cost cross-border transactions [5][9] Market Opportunities - The global remittance market is projected to exceed $1 trillion by 2030, with significant opportunities in cross-border payments, which currently incur an average fee of 6.5% and take days to settle [9][17] - XYRA's platform is designed to reduce settlement times and costs while addressing security risks associated with quantum computing, aiming to provide financial access to underserved populations [9][12] Future Outlook - Looking ahead to 2026, CTi plans to deepen strategic partnerships and explore additional opportunities aligned with the growing demand for efficient, sustainable, and chemical-free solutions [10] - The company is increasing its investment in research and development, supported by collaborations with universities, to advance CNTP™ toward commercial deployment [11]